27 related articles for article (PubMed ID: 11928630)
21. Clinical pharmacokinetics of therapeutic bile acids.
Crosignani A; Setchell KD; Invernizzi P; Larghi A; Rodrigues CM; Podda M
Clin Pharmacokinet; 1996 May; 30(5):333-58. PubMed ID: 8743334
[TBL] [Abstract][Full Text] [Related]
22. Cholemic nephropathy - Historical notes and novel perspectives.
Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
[TBL] [Abstract][Full Text] [Related]
23. [Disturbances in biliary secretion during tissue hypoxia and attempts at their corrections].
Hovorukha TM; Nazarenko AI; Zhalilo LI; Fil' HB; Baban VM; Seredenko MM
Fiziol Zh (1994); 2002; 48(1):35-40. PubMed ID: 11928630
[TBL] [Abstract][Full Text] [Related]
24. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
25. The effect of drugs on bile flow and composition. An overview.
Okolicsanyi L; Lirussi F; Strazzabosco M; Jemmolo RM; Orlando R; Nassuato G; Muraca M; Crepaldi G
Drugs; 1986 May; 31(5):430-48. PubMed ID: 2872047
[TBL] [Abstract][Full Text] [Related]
26. Biliary secretion: future perspectives.
Hofmann AF
Digestion; 1997; 58 Suppl 1():24-8. PubMed ID: 9225085
[No Abstract] [Full Text] [Related]
27. Mechanism of hepatoprotective action of bile salts in liver disease.
Stiehl A; Benz C; Sauer P
Gastroenterol Clin North Am; 1999 Mar; 28(1):195-209, viii. PubMed ID: 10198785
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
